Unknown

Dataset Information

Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion.


ABSTRACT:

Aims/hypothesis

Imbalances in glucose metabolism are hallmarks of clinically silent prediabetes (defined as impaired fasting glucose and/or impaired glucose tolerance) representing dysmetabolism trajectories leading to type 2 diabetes. CD26/dipeptidyl peptidase 4 (DPP4) is a clinically proven molecular target of diabetes-controlling drugs but the DPP4 gene control of dysglycaemia is not proven.

Methods

We dissected the genetic control of post-OGTT and insulin release responses by the DPP4 gene in a Portuguese population-based cohort of mainly European ancestry that comprised individuals with normoglycaemia and prediabetes, and in mouse experimental models of Dpp4 deficiency and hyperenergetic diet.

Results

In individuals with normoglycaemia, DPP4 single-nucleotide var

SUBMITTER: Patarrao RS 

PROVIDER: S-EPMC8960640 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature